Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Synvina’s FDCA plant delayed by two years
by Alex Scott
January 22, 2018
| A version of this story appeared in
Volume 96, Issue 4
Synvina, a joint venture between BASF and the Dutch firm Avantium, says it is delaying the start-up of its first commercial plant for the biobased chemical furandicarboxylic acid (FDCA) by two or three years to 2023 or 2024. Set to be built in Antwerp, Belgium, the plant will make the key raw material for a new biopolymer, polyethylene furanoate. Synvia says the delay is because it needs to iron out processing inefficiencies identified in the pilot production of FDCA.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter